ZAJ-17990-75330
4 vaccinations
1 coded response
37 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 200 / DC
- Registered
- 2021-06-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
A9W-33091-08049
Child or adolescent in my care · Female · 2022-08-06
Timeline
-
2021-06-02
Registered in v-safe
-
2021-06-08
Dose 1 — Pfizer-BioNTech
- 2021-06-12
- 2021-06-13
- 2021-06-14
- 2021-06-15
- 2021-06-22
-
2021-06-29
Dose 2 — Pfizer-BioNTech
-
2021-06-29
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-06-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-07-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-07-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-07-03
- 2021-07-04
- 2021-07-05
- 2021-07-06
- 2021-07-13
- 2021-07-20
- 2021-07-27
- 2021-08-03
- 2021-08-10
-
2021-09-28
Survey response — 3 months, dose 2MedDRA: Gestational diabetes — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Gestational diabetesMedDRA releases: 2024-11 · check-in free text available
-
2021-09-28
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-09-30
- 2021-12-28
-
2022-02-05
Dose 3 — Moderna
- 2022-02-05
-
2022-02-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2022-02-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fever · Headache, NauseaAdult check-in
- 2022-02-08
- 2022-02-09
- 2022-02-10
- 2022-02-11
- 2022-02-12
- 2022-02-19
- 2022-02-26
- 2022-03-05
- 2022-03-12
- 2022-03-19
- 2022-05-07
- 2022-08-06
-
2023-01-20
Dose 4 — Moderna
- 2023-02-05
- 2023-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-08 | Pfizer-BioNTech | |
| 2 | 2021-06-29 | Pfizer-BioNTech | No |
| 3 | 2022-02-05 | Moderna | No |
| 4 | 2023-01-20 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-28 | Unsuccessful |
Free text
Release 9 — 3 months, dose 2
Symptoms: Gestational diabetes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gestational diabetes | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release